2022 Genesis G80 2.5T
2.5 L • 4 • 300 hp • RWD • AT
KMTGB4SCXNU137682
Sales history: 1
Highlights
Condition
Run and drive
Seller
Insurance • GEICO
Key included
Yes
Docs
Good
History
1 record
Drive
2.5 L • 4 • 300 hp • RWD • AT
Odometer
36,532 mi ≈ 58,792 km
Primary damage
Front end
Secondary damage
Undercarriage
Docs
MD • Salvage >75% Damage
Auction
VIN
KMTGB4SCXNU137682
Lot number
46944565
Copart
Sale status
Sold
Seller type
Insurance
Seller
GEICO
Location
Baltimore East, MD
Description
Fuel type
Gasoline
Body color
Blue
Body type
Sedan
Generation
RG3
Trim
2.5T
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
2022 Genesis G80 2.5T • 2.5 L • 4 cyl • 300 hp • RWD • Automatic • Copart Lot: 46944565 • VIN: KMTGB4SCXNU137682
Find out more about this 2022 Genesis G80 2.5T, available at the Copart salvage car auction as lot #46944565 in Baltimore East, MD. This car has Front end main damage. It is listed with Run and drive start condition code. Odometer shows 36,532 mi. This Blue Genesis G80 Sedan is equipped with Gasoline 2.5 L engine, RWD drivetrain, Automatic transmission. Check the vehicle history report for KMTGB4SCXNU137682 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
